CASNumber33069-62-4
EmpiricalFormula(HillNotation)C47H51NO14
MolecularWeight853.91
BeilsteinRegistryNumber1420457
MDLnumberMFCD00869953
PubChemSubstanceID329750652
Properties:
RelatedCategories | AnalyticalStandards,Analytical/Chromatography,Pharmacopeia&MetrologicalInstitutesStandards,USPStandards,USPStandardsP-R |
Description:
Caution
Paclitaxelundergoestransesterificationinmethanolandhydrolyzesinaqueoussolutions.
Generaldescription
ThisproductisprovidedasdeliveredandspecifiedbytheissuingPharmacopoeia.Allinformationprovidedinsupportofthisproduct,includingSDSandanyproductinformationleafletshavebeendevelopedandissuedundertheAuthorityoftheissuingPharmacopoeia.ForfurtherinformationandsupportpleasegotothewebsiteoftheissuingPharmacopoeia
.
OtherNotes
Salesrestrictionsmayapply.
USPissuedSDScanbefoundhere
.
Biochem/physiolActions
Paclitaxelisapotentanti-neoplasticandanti-mitotictaxanedrug,whichbindstotheN-terminusofβ-tubulinandandstABIlizesmicrotubulesarrestingthecellcycleattheG2/Mphase.ThemicrotubuledamageinducesapoptosisthroughaJNK-dependentpathwayfollowedbyaJNK-independentpathway,perhapsrelatedtotheactivationofproteinkinaseA(PKA)orofRaf-1kinase,resultinginphosphorylationofBcl-2.AmajormetaboliteviaCYP2CBis6α-hydroxypaclitaxel(6α-OHP).
Safety:
Hazardstatements
H315-H317-H318-H334-H335-H341-H361
Precautionarystatements
P261-P280-P284-P304+P340-P305+P351+P338+P310-P342+P311
RIDADR
NONHforallmodesoftransport